US 11932703
Anti-ROR1 antibody and ROR1-targeting engineered cells
granted A61KA61K40/11A61K40/31
Quick answer
US patent 11932703 (Anti-ROR1 antibody and ROR1-targeting engineered cells) held by Caribou Biosciences, Inc. expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Caribou Biosciences, Inc.
- Grant date
- Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K40/11, A61K40/31, A61K40/4202, A61P